In patients with Chronic Myeloid Leukemia
ABL gene on Chr. 22 is trans-located to BCR gene on Chr.9 The fusion gene bcr-abl forms a protein with tyrosine kinase activity Splenomegaly is unusual Philadelphia chromosome positive patients respond poorly to Imatinib